United States· US:23155-235_5b65cafb-4e53-4197-a872-c12ffdbc04e4
glyburide-metformin hydrochloride
A sulfonylureas product containing glyburide-metformin hydrochloride, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- glyburide-metformin hydrochloride
- Manufacturer
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- A10BB
- ATC class
- Sulfonylureas
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 3
- ndc112315523501100 TABLET in 1 BOTTLE (23155-235-01)
- ndc112315523505500 TABLET in 1 BOTTLE (23155-235-05)
- ndc1123155235101000 TABLET in 1 BOTTLE (23155-235-10)
Regulatory notes
Same class
Other records under A10BB
Sulfonylureas, as other registers publish it.
- United StatesGlipizide and Metformin HClHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesGlipizide and Metformin HClHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesGlipizide and Metformin HClHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesGlipizide and Metformin HydrochlorideZydus Pharmaceuticals USA Inc.
- United StatesGlipizide and Metformin HydrochlorideZydus Pharmaceuticals USA Inc.
- United StatesGlipizide and Metformin HydrochlorideZydus Pharmaceuticals USA Inc.
- United Statesglyburide and metformin hydrochlorideZydus Lifesciences Limited
- United Statesglyburide and metformin hydrochlorideZydus Lifesciences Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c21f03e2-5b8b-4c4a-bb2d-91bb9661c585 GET /v1/drugs/c21f03e2-5b8b-4c4a-bb2d-91bb9661c585?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "SX6K58TVWC",
"rxcui": "4815",
"inchikey": "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
"display_name": "GLYBURIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"b38213bb-d663-4c95-a1b2-96c23ee5be09": {
"match": "brand_token",
"title": "GLYBURIDE-METFORMIN HYDROCHLORIDE TABLET [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.]",
"spl_version": "15",
"published_date": "2026-04-27"
}
},
"productid": "23155-235_5b65cafb-4e53-4197-a872-c12ffdbc04e4",
"productndc": "23155-235",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "079009",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "1.25MG;250MG",
"product_no": "001",
"approval_date": "Jun 3, 2009"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "2.5MG;500MG",
"product_no": "002",
"approval_date": "Jun 3, 2009"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "5MG;500MG",
"product_no": "003",
"approval_date": "Jun 3, 2009"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "GLYBURIDE; METFORMIN HYDROCHLORIDE",
"proprietary_name": "glyburide-metformin hydrochloride",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA079009",
"marketing_category": "ANDA",
"nonproprietary_name": "glyburide-metformin hydrochloride",
"start_marketing_date": "20240501",
"active_numerator_strength": "5; 500"
}See everything about glyburide-metformin hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.